News
SmartLabs, a First-of-Its-Kind Laboratory-as-a-Service, Expands Nationally with CA Location
Boston-based Laboratory-as-a-Service (LaaS) leader, SmartLabs, announced a national expansion with the addition of 80,000 square feet in South San Francisco, California. Building upon its continued success in Massachusetts, SmartLabs’s new San Francisco laboratories will deliver high quality, turnkey R&D...
Drug Research
Altasciences Adds Comprehensive Contract Manufacturing and Analytical Services to its Early Phase Research Offering
Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage drug development from lead candidate selection to proof of concept, announced that it has acquired Alliance Contract Pharma. This acquisition adds small molecule contract...
News
Samsung Biologics & STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
Samsung Biologics and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate.
Under the agreement, Samsung Biologics will offer a wide range of services from cell line development, process development, manufacturing of non-clinical...
News
Recipharm names 2019 International Environmental Award winner
Recipharm has announced its 2019 International Environmental Award will be presented to Dana Kolpin, Research Hydrologist at the U.S. Geological Survey Central Midwest Water Science Center in Iowa City, Iowa.
Dana Kolpin’s extensive expertise in source-to-receptor research includes the impact...
News
CPhI Japan to be postponed on request of event attendees
CPhI Japan – organised by Informa Markets – announces that the event will be postponed until a new date later in the year after extensive consultation with key stakeholders and consideration of all alternatives. The event, which was due...
Clinical Trials
IQVIA Launches Avacare Clinical Research Network to Increase Patients Clinical and Research Options
IQVIA™ (NYSE: IQV), a leader in human data science, announced the launch of Avacare Clinical Research Network™, a technology-based global site network that opens opportunities for more clinical trials at experienced clinical and research sites. Avacare’s unique analytical tools...
Drug Research
Novartis and DNDi to jointly develop a new oral drug to treat visceral leishmaniasis
Swiss pharma giant Novartis and non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) have signed a collaboration and license agreement to jointly develop LXE408 for visceral leishmaniasis.
LXE408 is an oral treatment for this parasitic disease, which...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read